Inventor · disambiguated record
Qinwei Wang
Also filed as: WANG QINWEI
14 granted patents·12 pending applications·66 citations·filing 2006–2024
87Inventor score
Files withTAO CHUNLIN7ABRAXIS BIOSCIENCE LLC6NANTBIOSCIENCE INC6NANTBIO INC4ABRAXIS BIO SCOENCE INC1
Top patents by PatentIndex Score
26 records- 0196US7858782B2Triazine derivatives and their therapeutical applicationsABRAXIS BIOSCIENCE LLC·Filed 2007·Granted Dec 28, 2010·54 cites·6 claims
- 0288US9458137B2Substituted indol-5-ol derivatives and their therapeutical applicationsNANTBIOSCIENCE INC·Filed 2013·Granted Oct 4, 2016·7 cites·9 claims
- 0378US8580786B2Triazine derivatives and their therapeutical applicationsDESAI NEIL P·Filed 2010·Granted Nov 12, 2013·3 cites·1 claims
- 0471US10344026B2Compositions and methods of targeting mutant K-rasNANTBIO INC·Filed 2018·Granted Jul 9, 2019·1 cites·15 claims
- 0568US9409903B2Benzyl substituted triazine derivatives and their therapeutical applicationsNANTBIOSCIENCE INC·Filed 2014·Granted Aug 9, 2016·1 cites·3 claims
- 0664US2025205312A1Orally Available AlbenatideALBUNEXT LLC·Filed 2024·Application pending·0 cites
- 0763US2017203012A1Drugs with improved hydrophobicity for incorporation in medical devicesABRAXIS BIOSCIENCE LLC·Filed 2017·Application pending·0 cites
- 0860US2018318473A1Drugs with improved hydrophobicity for incorporation in medical devicesABRAXIS BIOSCIENCE LLC·Filed 2018·Application pending·0 cites
- 0959US7799954B2Dicarbonyl derivatives and methods of useABRAXIS BIOSCIENCE LLC·Filed 2007·Granted Sep 21, 2010·0 cites·60 claims
- 1058US2015190556A1Drugs with improved hydrophobicity for incorporation in medical devicesABRAXIS BIOSCIENCE LLC·Filed 2015·Application pending·0 cites
- 1158US2009130163A1Drugs With Improved Hydrophobicity For Incorporation in Medical DevicesABRAXIS BIO SCOENCE INC·Filed 2006·Application pending·0 cites
- 1256US10160749B2Substituted indol-5-ol derivatives and their therapeutical applicationsNANTBIOSCIENCE INC·Filed 2016·Granted Dec 25, 2018·0 cites·14 claims
- 1353US10800760B2Trk inhibitionNANTBIO INC·Filed 2018·Granted Oct 13, 2020·0 cites·2 claims
- 1451US10245261B2Substituted indol-5-ol derivatives and their therapeutic applicationsNANTBIOSCIENCE INC·Filed 2016·Granted Apr 2, 2019·0 cites·16 claims
- 1550US2010279963A1Dicarbonyl derivatives and methods of useABRAXIS BIOSCIENCE LLC·Filed 2010·Application pending·0 cites
- 1649US10766879B2Pyrimidine derivatives as kinase inhibitors and their therapeutical applicationsNANTBIOSCIENCE INC·Filed 2015·Granted Sep 8, 2020·0 cites·9 claims
- 1747US2018215734A1Pyrimidine derivatives as kinase inhibitors and their therapeutical applicationsNANTBIOSCIENCE INC·Filed 2016·Application pending·0 cites
- 1841US10392397B2Heterocyclic thiosemicarbazone derivatives and their therapeutical applicationsNANTBIO INC·Filed 2016·Granted Aug 27, 2019·0 cites·11 claims
- 1941US8877924B2Benzyl substituted triazine derivatives and their therapeutical applicationsTAO CHUNLIN·Filed 2010·Granted Nov 4, 2014·0 cites·11 claims
- 2039US10738033B2Trk inhibitionNANTBIO INC·Filed 2018·Granted Aug 11, 2020·0 cites·7 claims
- 2133US9078902B2Triazine derivatives and their therapeutical applicationsTAO CHUNLIN·Filed 2010·Granted Jul 14, 2015·0 cites·5 claims
- 2233US2012178758A1Styryl-triazine derivatives and their therapeutical applicationsTAO CHUNLIN·Filed 2010·Application pending·0 cites
- 2332US2012172361A1Triazine derivatives and their therapeutical applicationsTAO CHUNLIN·Filed 2010·Application pending·0 cites
- 2432US2013023497A1Triazine Derivatives and their Therapeutical ApplicationsTAO CHUNLIN·Filed 2010·Application pending·0 cites
- 2530US2012238576A1Triazine Derivatives and their Therapeutical ApplicationsTAO CHUNLIN·Filed 2010·Application pending·0 cites
- 2629US2012202818A1Ureidophenyl substituted triazine derivatives and their therapeutical applicationsTAO CHUNLIN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qinwei Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →